New Study Reveals Ozempic, Wegovy Linked To 'Potentially Blinding Eye Condition'

New Study Reveals Ozempic, Wegovy Linked To 'Potentially Blinding Eye Condition' Shares of Novo Nordisk and Eli Lilly extended declines after Mass Eye and Ear, a Harvard-affiliated hospital, revealed in a new study published in the journal JAMA Ophthalmology that people prescribed semaglutide, sold as Ozempic and Wegovy (Novo), have an elevated risk of developing a "potentially blinding eye condition" called nonarteritic anterior ischemic optic neuropathy (NAION). "The study found people with diabetes who had been prescribed semaglutide by their physician and then filled the prescription were more than four...